> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letters
- URL: https://www.fdaweb.com/latest-fda-warning-letters-55/
- Published: 2021-02-23T12:00:00.000Z
- Updated: 2026-09-14T16:48:00.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148727

FDA has posted its latest batch of Warning Letters. They can be accessed by clicking on the link following each letter.

**CooperSurgical**, Trumbull, CT (2/12): CDER’s Office of Prescription Drug Promotion (OPDP) cited the firm’s direct-to-consumer video for Paragard (intrauterine copper contraceptive) as false and misleading due to presenting product efficacy claims and failing to communicate any risk information associated with its use. OPDP says that referring viewers to a Web site for further information does not mitigate the complete omission of risk information from the video. It also says the company failed to submit a copy of the video at the time of initial dissemination with a copy of the FDA-2253 as required by regulations. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/coopersurgical-inc-613339-02122021?ref=fdaweb.com).

**Dr. Paul's Lab**, Mazomanie, WI (2/16): FDA has reviewed the firm’s Web site ([http://drpaulslab.net](http://drpaulslab.net/?ref=fdaweb.com)) that directs consumers to various dealers to purchase its product, which the agency determined is an unapproved drug because it is intended to mitigate, prevent, treat, diagnose, or cure Covid-19\. For example, FDA objected to the following claim: “Covid-Aid Tincture . . . Directions: If illness \[is\] suspected, take 1 cc (1 dropperful) under tongue 4–6 times daily until symptoms subside.” To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-pauls-lab-612964-02162021?ref=fdaweb.com).